Roundview Capital LLC Novartis Ag Transaction History

Roundview Capital LLC

$1.2 Billion
Q1 2024

A detailed history of Roundview Capital LLC transactions in Novartis Ag stock. As of the latest transaction made, Roundview Capital LLC holds 2,694 shares of NVS stock, worth $296,178. This represents 0.02% of its overall portfolio holdings.

Number of Shares

2,694

Previous 2,924 7.87%

Holding current value

$296,178

Previous $295,000 11.86%

% of portfolio

0.02%

Previous 0.03%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 06, 2024	SELL	$95.27 - $108.47 $21,912 - $24,948	-230 Reduced 7.87%	2,694 $260,000
Q4 2023 Feb 12, 2024	SELL	$92.27 - $101.54 $3,229 - $3,553	-35 Reduced 1.18%	2,924 $295,000
Q1 2023 May 09, 2023	SELL	$80.03 - $92.81 $466,334 - $540,803	-5,827 Reduced 66.32%	2,959 $272,000
Q3 2022 Nov 10, 2022	BUY	$74.61 - $87.26 $1,790 - $2,094	24 Added 0.27%	8,786 $668,000
Q1 2022 May 11, 2022	SELL	$80.11 - $90.62 $6,168 - $6,977	-77 Reduced 0.87%	8,762 $769,000

Q4 2021 Feb 10, 2022	SELL	$79.7 - $88.13 $71,490 - $79,052	-897 Reduced 9.21%	8,839 $773,000
Q3 2021 Nov 10, 2021	SELL	$81.78 - $95.14 $11,694 - $13,605	-143 Reduced 1.45%	9,736 $796,000
Q1 2021 May 14, 2021	BUY	$83.5 - $98.47 $12,692 - $14,967	152 Added 1.56%	9,879 $844,000
Q4 2020 Feb 08, 2021	BUY	$78.07 - $94.43 $3,122 - $3,777	40 Added 0.41%	9,727 $919,000
Q3 2020 Nov 05, 2020	SELL	$82.14 - $91.0 $657 - $728	-8 Reduced 0.08%	9,687 $842,000
Q2 2020 Aug 13, 2020	SELL	$80.93 - $91.1 $16,347 - $18,402	-202 Reduced 2.04%	9,695 $847,000
Q1 2020 May 11, 2020	BUY	$70.67 - $99.01 $57,030 - $79,901	807 Added 8.88%	9,897 $816,000
Q4 2019 Feb 10, 2020	BUY	$84.35 - $95.37 $4,892 - $5,531	58 Added 0.64%	9,090 $861,000
Q3 2019 Nov 12, 2019	BUY	$85.54 - $94.26 $12,403 - $13,667	145 Added 1.63%	9,032 $785,000
Q2 2019 Aug 12, 2019	BUY	$75.4 - $92.8 $23,147 - $28,489	307 Added 3.58%	8,887 $811,000
Q1 2019 May 09, 2019	BUY	$75.32 - $86.15 $33,894 - $38,767	450 Added 5.54%	8,580 $825,000
Q4 2018 Feb 13, 2019	BUY	$73.66 - $82.02 $96,862 - $107,856	1,315 Added 19.3%	8,130 $698,000
Q3 2018 Nov 07, 2018	BUY	$66.94 - $77.43 $16,735 - $19,357	250 Added 3.81%	6,815 $587,000
Q2 2018 Aug 10, 2018	BUY	$64.91 - $73.36 $43,814 - $49,518	675 Added 11.46%	6,565 $496,000
Q1 2018 May 14, 2018	SELL	$70.39 - $84.15 $166,472 - $199,014	-2,365 Reduced 28.65%	5,890 $476,000
Q4 2017 Feb 07, 2018	BUY	$72.33 - $77.64 $73,776 - $79,192	1,020 Added 14.1%	8,255 $693,000
Q3 2017 Nov 13, 2017	SELL	$74.14 - $77.27 $4,448 - $4,636	-60 Reduced 0.82%	7,235 $621,000
Q3 2017 Nov 13, 2017	BUY	$74.14 - $77.27 $540,851 - $563,684	7,295	7,295 $609,000

Others Institutions Holding NVS

# of Institutions

1,352

Shares Held

140M

Call Options Held

1.15M

Put Options Held

866K

View Full List

About NOVARTIS AG

Ticker NVS
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,151,000,064
Market Cap $236B
Description
Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...

More about NVS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Roundview Capital LLC, based on Form 13F filings with the SEC.

News

Stay updated on Roundview Capital LLC with notifications on news.

Account

Roundview Capital LLC Novartis Ag Transaction History